Ana Rita Grosso gathered a Biology degree (FCUL, 2002), followed by a MSc in Bioinformatics (FCUL-IGC, 2006). Her multi-omics expertise in biomedical research was accomplished by gathering a PhD in Biomedical Sciences (iMM/FMUL, 2010), where she unveiled the existence of splicing-factors expression signatures responsible by the tissue-specific regulation of alternative splicing. During her PostDoc (iMM) she disclosed new mechanisms underlying epigenetics, transcription and splicing dynamics. In 2018, Ana Rita Grosso moved to NOVA School of Science and Technology (NOVA-FCT) and Applied Molecular Biosciences Unit (UCIBIO) to foster her scientific independence and consolidate her research group: Computational Multi-Omics. Her main mission is to decipher pathological conditions using multi-omics approaches, identifying molecular events to be further used as biomarkers and therapeutic targets. Highlighting, she has been unveiling (epi)genome/transcriptome alterations that affects tumor evolution and metastasis development. To date, Ana Rita Grosso published 51 papers and 2 chapter books (enclosing 2401 citations). Also, she won in highly competitive schemes: 4 Salary Grants (PhD and PostDoc Fellowships, 2 Research Contracts); 11 Projects Grants (5 as PI/Co-PI and 7 as Team Member, including La Caixa Research Health), 1 EMBO Workshop, as well as 3 Pfizer Awards for Basic Research. Finally, she has been fostering advance training in the computational biology field by supervising 4 PostDoc researchers, 4 PhD students, 3 MSc fellows, 10 MSc students, 7 BSc students and several short-term trainees. Additionally, she has been teaching MSc and BSc courses focused on Genomics and Computational Biology fields in NOVA-FCT.